FcεR1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment

PLoS One. 2012;7(8):e43547. doi: 10.1371/journal.pone.0043547. Epub 2012 Aug 16.

Abstract

Background: Mast cell-derived mediators mediate several of the pathological features of asthma. Microbial infections induce asthma exacerbations in which the contribution of mast cells remains incomprehensible.

Principal findings: In this study we have investigated the characteristic expression pattern of Toll-like receptors (TLRs) 1-9 and the effect of TLR ligand treatment on IgE-receptor mediated mast cell reactivity. For the studies we employed in vitro differentiated connective tissue like mast cells (CTLMC) and mucosal like mast cells (MLMC) from mice. Both phenotypes were treated for 24 h or 96 h with ligands for TLR1/2, TLR2/6, TLR3 and TLR4, before activation with IgE and antigen. Prolonged exposure (96 h) with TLR-ligands promoted mast cell reactivity following IgE-receptor activation. TLR4 activation with LPS generated the most pronounced effect, with an enhanced degranulation and secretion of leukotrienes, cytokines and chemokines, in both CTLMC and MLMC. The effect of LPS was mediated through a Myd88-dependent pathway and the increased effect involved JNK-dependent pathway.

Conclusion: We find that prolonged exposure of mast cells to pathogens/TLR-ligands modulates their effector responses by priming them for increased release of several inflammatory mediators when subsequently activated by IgE-receptors. These data suggest that infections might exaggerate the severity of allergic reactions such as in asthma, by enhancing mediator release from mast cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cells, Cultured
  • Chemokines / metabolism
  • Cytokines / metabolism
  • Leukotrienes / metabolism
  • Lipopolysaccharides / pharmacology
  • Mast Cells / drug effects*
  • Mast Cells / metabolism*
  • Mice
  • Real-Time Polymerase Chain Reaction
  • Receptors, IgE / metabolism
  • Toll-Like Receptors / agonists*

Substances

  • Chemokines
  • Cytokines
  • Leukotrienes
  • Lipopolysaccharides
  • Receptors, IgE
  • Toll-Like Receptors

Grants and funding

The study was supported by the Swedish Research Council – Medicine, The Swedish Heart and Lung Foundation, the Centre for Allergy Research at Karolinska Institutet, King Gustaf V’s 80-years Foundation, Ollie and Elof Ericsson’s foundation, Hans von Kantzow’s foundation, and Ellen, Walter and Lennart Hesselman’s foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.